scholarly journals Case Report: Insulinoma Presenting as Excessive Daytime Somnolence

2021 ◽  
Vol 12 ◽  
Author(s):  
Zhennan Yu ◽  
Yongliang Wang ◽  
Yaqi Sun ◽  
Yumei Wang ◽  
Yayun Tian ◽  
...  

Currently, undiagnosed insulinomas remain a difficult clinical dilemma because its symptoms in most cases can easily be misdiagnosed as other diseases. In this article, we present the case of a 14-year-old girl who presented to our hospital with recurrent episodes of excessive daytime sleepiness and abnormal behavior during sleep that had been going on for 3 months. Insulinoma is a rare neuroendocrine tumor that causes excessive release of insulin, resulting in episodes of hypoglycemia. It usually manifests as autonomic sympathetic symptoms. These symptoms resolved rapidly with the administration of glucose. After successful removal of the tumor, daytime sleepiness and abnormal nighttime behavior of the patient did not reappear.

Author(s):  
Jeny Jacob ◽  
Rajesh Venkataram ◽  
Nandakishore Baikunje ◽  
Rashmi Soori

AbstractNarcolepsy, a sleep disorder, has its onset in childhood and early adulthood but rarely in older adults. This case report focuses on a man in his late fifties who was noticed to have excessive daytime sleepiness during his stay in our hospital for an unrelated medical ailment. He was further evaluated with overnight polysomnography and next day multiple sleep latency test which confirmed the diagnosis of narcolepsy.


2014 ◽  
Vol 23 (4) ◽  
pp. 369-376 ◽  
Author(s):  
Pierre Philip ◽  
Stéphanie Bioulac ◽  
Alain Sauteraud ◽  
Cyril Chaufton ◽  
Jérôme Olive

Excessive daytime somnolence (EDS) is defined as the inability to stay awake in daily life activities. Several scales have been used to diagnose excessive daytime sleepiness, the most widely used being the Epworth Sleepiness Scale (ESS). Sleep disorders and EDS are very common in the general population. It is therefore important to be able to screen patients for this symptom in order to obtain an accurate diagnosis of sleep disorders. Embodied Conversational Agents (ECA) have been used in the field of affective computing and human interactions but up to now no software has been specifically designed to investigate sleep disorders. We created an ECA able to conduct an interview based on the ESS and compared it to an interview conducted by a sleep specialist. We recruited 32 consecutive patients and a group of 30 healthy volunteers free of any sleep complaints. The ESS is a self-administered questionnaire that asks the subject to rate (with a pen and paper paradigm) his or her probability of falling asleep. For the purpose of our study, the ECA or real-doctor questionnaire was modified as follows: Instead of the “I” formulate, questions were asked as “Do you.” Our software is based on a common 3D game engine and several commercial software libraries. It can run on standard and affordable hardware products. The sensitivity and specificity of the interview conducted by the ECA were measured. The best results (sensibility and specificity >98%) were obtained to discriminate the sleepiest patients (ESS ≥16) but very good scores (sensibility and specificity >80%) were also obtained for alert subjects (ESS<8). ESS scores obtained in the interview conducted by the physician were significantly correlated with ESS scores obtained in the interview the ECA conducted. Most of the subjects had a positive perception of the virtual physician and considered the interview with the ECA as a good experience. Sixty-five percent of the participants felt that the virtual doctor could significantly help real physicians. Our results show that a virtual physician can conduct a very simple interview to evaluate EDS with very similar results to those obtained by a questionnaire administered by a real physician. The expected massive increase in sleep complaints in the near future likely means that more and more physicians will be looking for computerized systems to help them to diagnose their patients.


Nosotchu ◽  
2020 ◽  
Vol 42 (2) ◽  
pp. 94-99
Author(s):  
Shota Nishimoto ◽  
Hitoshi Fukuda ◽  
Naoki Fukui ◽  
Yusuke Ueba ◽  
Fumihiro Hamada ◽  
...  

2014 ◽  
Vol 8 (1) ◽  
Author(s):  
Sara V Weselake ◽  
Jessica L Foulds ◽  
Robert Couch ◽  
Manisha B Witmans ◽  
Daniela Rubin ◽  
...  

Author(s):  
Mahya Shabani ◽  
Besharat Rahimi ◽  
Mohammad Mehdi Mehrabi Nejad ◽  
Reza Erfanian ◽  
Arezu Najafi

Coronavirus infectious disease 2019 (COVID-19) is confirmed to develop neurocognitive complications. In the present paper, we describe two patients with laboratory-confirmed COVID-19 and excessive daytime sleepiness. In the present study, we reported two laboratory-confirmed cases of COVID-19 with excessive daytime sleepiness. Patients had drowsiness and mild confusion on presentation. In both cases, CNS infections, including meningitis and encephalitis, were ruled out. Both patients’ symptoms remarkably improved following the therapeutic course indicating the direct effect of SARS-CoV2 in sleep modulating centers on the brain. COVID-19 should be considered in patients with excessive daytime sleepiness and drowsiness in the current outbreak.


Sign in / Sign up

Export Citation Format

Share Document